Zhengye Biotechnology Holding Limited (ZYBT)

CIK 0001975641 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Audit Information
—
Statements
Consolidated Balance Sheets
—
Consolidated Balance Sheets (P)
—
Consolidated Statements of Income and Comprehensive Income
—
Consolidated Statements of Operations and Comprehensive Income (loss)
—
Consolidated Statements of Changes In Shareholders Equity
—
Consolidated Statements of Cash Flows
—
Notes
Accounts Receivable, Net
—
Accrued Expenses and Other Liabilities
—
Commitments and Contingencies
—
Condensed Financial Information of The Parent Company
—
Cybersecurity Risk Management and Strategy Disclosure
—
Insider Trading Policies and Procedures
—
Intangible Assets, Net
—
Inventories, Net
—
Land Use Rights, Net
—
Leases
—
Loans
—
Notes Receivable, Net
—
Organization
—
Pay Vs Performance Disclosure
—
Prepayment and Other Assets, Net
—
Property, Plant and Equipment, Net
—
Related Party Transactions
—
Related Party Transcations
—
Restricted Net Assets
—
Segment Information
—
Shareholder's Equity
—
Short-term Investments
—
Subsequent Events
—
Summary of Significant Accounting Policies
—
Taxation
—